Covid-19 treatments: latest on research

Effective treatments for Covid-19 could help change the course of this pandemic – from saving lives to reducing the pressure on healthcare systems. A collective global effort is needed to fund, research, develop and bring effective treatments to people, as soon as possible.

When will we have effective treatments?

Research into treatments for Covid-19 is moving at an incredible speed – with thousands of studies in progress and more than 400 potential therapies being explored. 

Large randomised clinical trials, such as the World Health Organization’s Solidarity clinical trial and the UK’s RECOVERY trial, are essential for learning which treatments are safe and effective.

Most of the current research focuses on repurposed drugs – if shown to be effective, these could be rapidly rolled out across the world. Among the new drugs that are being developed specifically for Covid-19, monoclonal antibodies are some of the most promising ones. 


Inside the RECOVERY Trial: the largest clinical trial for Covid-19 treatments

How we’re supporting research

We launched the COVID-19 Therapeutics Accelerator together with the Bill & Melinda Gates Foundation and Mastercard.

This is a large-scale collaboration to research, develop and bring effective treatments to market quickly and accessibly. The studies funded so far include evaluating approved drugs and creating platforms for exploring new potential treatments.

Find out how to apply for funding from or donate to the Therapeutics Accelerator.

Treatments for everyone

Any – and all – effective treatments for Covid-19 must be available to everyone around the world. Those who need them most, not those who can afford to buy them, should have access first.

The ACT Accelerator, a global collaboration of governments and international organisations, was set up to support the development, production and equitable access to all tools that will help protect people against Covid-19.


More opinion

Read more articles on Covid-19.